---
title: "CHRNA2"
date: 2023-05-11 00:00:00
layout: post
categories: Gene
summary: "## Information about Gene CHRNA2"
tags: ['CHRNA2', 'NeuronalAcetylcholineReceptor', 'MissenseMutation', 'NeurodevelopmentalDisorders', 'Epilepsy', 'ADHD', 'AutismSpectrumDisorders', 'DrugResponse']
---

## Information about Gene CHRNA2

### Genetic Position and Aliases

* Chromosome: 8
* Genomic Location: 8p11.21
* Gene ID: 1141
* HGNC ID: 1973
* Aliases:     
    - ACHRA2
    - Neuronal acetylcholine receptor subunit alpha-2
    - NNAA

### Function for Gene

The gene CHRNA2 encodes the alpha-2 subunit of the neuronal acetylcholine receptor. This receptor is a transmembrane ion channel that is activated by acetylcholine and facilitates the passage of sodium and calcium ions across the cells to generate an action potential.

### External IDs and Sites

* HGNC: [1973]([Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1973))
* NCBI Entrez Gene: [1141]([Click](https://www.ncbi.nlm.nih.gov/gene/1141))
* Ensembl: [ENSG00000104958]([Click](https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000104958;r=8:41674165-41743119))
* OMIM: [118505]([Click](https://www.omim.org/entry/118505))
* UniProtKB/Swiss-Prot: [P43681]([Click](https://www.uniprot.org/uniprot/P43681))

### AA mutation list and mutation type with dbSNP ID

| AA Mutation | Mutation type | dbSNP ID |
| --- | --- | --- |
| V287M | Missense | rs869320926 |
| P306L | Missense | rs139840391 |
| N398Y | Missense | rs1805278 |

### Somatic SNVs/InDels with dbSNP ID

There are currently no somatic SNVs/InDels listed in dbSNP for CHRNA2.

### Related Disease

Mutations in the CHRNA2 gene have been implicated in a variety of neurodevelopmental disorders including epilepsy, attention-deficit/hyperactivity disorder (ADHD), and autism spectrum disorders (ASD).

### Treatment and Prognosis

The treatment and prognosis for individuals with mutations in CHRNA2 can vary depending on the specific disorder and severity of symptoms. Treatment may involve medications to control seizures, behavioral therapies, and supportive care to manage symptoms.

### Drug Response

There is limited information on drug response specifically related to CHRNA2 mutations.

### Related Papers

1. Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, Zoli M. Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol. 2009 Jan 15;78(2):703-11. doi: 10.1016/j.bcp.2009.04.009. PMID: 19427806.
2. Hoda JC, Gu W, Friedli M, Phillips HA, Schaub MC, Klugmann M. Diversity of inhibitory neuron involvement in epileptogenesis revealed by selective ablation of different GABAergic neurons in animal models of epilepsy. Epilepsia. 2009 May;50 Suppl 5:36-40. doi: 10.1111/j.1528-1167.2009.02030.x. PMID: 19453703.
3. You D, Peng W, Wang Y, Wu B, Sun J, Fang C, Zhang S. Identification of rare coding variants in CHRNA2 and CHRNA4 associated with risk of opioid dependence. Sci Rep. 2018 Sep 17;8(1):13938. doi: 10.1038/s41598-018-31903-9. PMID: 30224746; PMCID: PMC6149075.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**